NCT02058758View on ClinicalTrials.gov

Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2014

Primary Completion Date

July 1, 2019

Study Completion Date

September 1, 2019

Conditions
Breast Cancer
Interventions
DEVICE

Magnetic Resonance Imaging

MRI scanning with novel acquisition, reconstruction, and/or analysis methods.

Trial Locations (1)

55455

University of Minnesota Center for Clinical Imaging Reserach, Minneapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Minnesota

OTHER

NCT02058758 - Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast Cancer | Biotech Hunter | Biotech Hunter